Scandinavian Medical Solutions A/S
SMSMED.CO · CPH
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Growth | 8.3% | 18.6% | 73% | – |
| Cost of Goods Sold | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Gross Profit | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Margin | 14% | 17.7% | 18.2% | 20.5% |
| R&D Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| G&A Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| SG&A Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Sales & Mktg Exp. | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Operating Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Operating Income | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Margin | 0.7% | 6.1% | 8.7% | 13.3% |
| Other Income/Exp. Net | -DKK 0 | -DKK 0 | -DKK 0 | -DKK 0 |
| Pre-Tax Income | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Tax Expense | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Net Income | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Margin | 0% | 3.4% | 6.4% | 10.3% |
| EPS | 0.001 | 0.28 | 0.45 | 0.43 |
| % Growth | -99.7% | -37.8% | 4.7% | – |
| EPS Diluted | 0.001 | 0.28 | 0.45 | 0.43 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Interest Expense | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Depreciation & Amortization | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| EBITDA | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Margin | 4.5% | 9.3% | 11.1% | 14.1% |